HCW Biologics Inc

-0.12 (-5.26%)
Earnings Announcements

HCW Biologics Inc Reports Quarterly Net Loss Per Share Of $0.11

Published: 11/07/2022 22:17 GMT
HCW Biologics Inc (HCWB) - Hcw Biologics Reports Third Quarter 2022 Financial Results and Recent Business Highlights.
Hcw Biologics Inc - As of September 30, 2022, Company Had Cash and Cash Equivalents and Investments of $35.9 Million.
Hcw Biologics Inc - Qtrly Revenues of $1.8 Million, There Were No Revenues in Three-month Period Ended September 30, 2021.
Hcw Biologics Inc - Qtrly Net Loss per Share of $0.11.
Hcw Biologics Inc - Company Estimates That Current Cash Balance is Sufficient to Fund Operations and Capital Expenditures Through End of 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.15

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.